CSIMarket
 


Burzynski Research Institute Inc  (BZYR)
Other Ticker:  
 


Burzynski Research Institute Inc's Net Profit Margin by quarter

Trends, Rankings, Statistics



BZYR Net Profit Margin (Nov 30 2023)
III. Quarter
(Aug 31 2023)
II. Quarter
(May 31 2023)
I. Quarter
(Feb 28 2023)
IV. Quarter
(Nov 30 2022)
III. Quarter
Y / Y Revenue Change - - - - -
Seq. Revenue Change - - - - -
Revenue In Millions $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit Margin - - - - -
Net Profit Margin Total Ranking # # # # #
Net Income In Millions $-0.43 $-0.25 $-0.29 $-0.22 $-0.25
Y / Y Net Income Change - - - - -
Seq. Net Income Change - - - - -


Commenting Third Quarter 2023 Net Profit Margin
Burzynski Research Institute Inc achived higher Net Loss of 0 then a $-0.25 millions reported a quarter before.

Observing third quarter 2023 results within In Vitro & In Vivo Diagnostic Substances industry Burzynski Research Institute Inc has achieved highest Net Profit Margin. While overall Net Profit Margin ranking remained unchanged compare to previous quarter at no. .
Net Margin Formula
BZYR's Net Profit Margin third quarter 2023 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall # 0

Net Profit Margin Statistics
High Average Low
0 % 0 % 0 %
 




Other Net Profit Margin Profitability Ratios
BZYR's Cumulative Net Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Net Profit Margin Trends and Statistics
Healthcare Sector Net Profit Margin Statistics
Net Profit Margin Profitability Trends for overall market
BZYR's Net Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Net Profit Margin
Lowest Ranking Net Profit Margin
Net Profit Margin Profit Margin for BZYR's Competitors
Net Profit Margin Profit Margin for Burzynski Research Institute Inc's Suppliers
Net Profit Margin Profit Margin for BZYR's Customers

You may also want to know
BZYR's Annual Growth Rates BZYR's Profitability Ratios BZYR's Asset Turnover Ratio BZYR's Dividend Growth
BZYR's Roe BZYR's Valuation Ratios BZYR's Financial Strength Ratios BZYR's Net Income Growth
BZYR's Roa BZYR's Inventory Turnover Ratio BZYR's Growth Rates BZYR's Dividend Comparisons


Companies with similar Net Profit Margin in the quarter ending Nov 30 2023, within In Vitro & In Vivo Diagnostic Substances Industry Net Profit MarginNov 30 2023 MRQ Net IncomeNov 30 2023 MRQ Revenue




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com